LenoMed Medical
Latest round
- Series C
Last raised
- Jun 2021
Total raised
- $28M
Investors
- 7
About LenoMed Medical
Based in Shanghai, China and established in 2014, LenoMed Medical is a medical technology that engages in the research and development and manufacturing of drug infusion devices. The company's main products are drug infusion devices, including insulin Pump, GnRH (gonadotropin-releasing hormone) pump, smart medicine box and cloud management application of chronic diseases. These products are mainly used in the field of diabetes and pituitary hormone therapy.
Who invested in LenoMed Medical
7 investors across 5 rounds
See all investors in LenoMed Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LenoMed Medical
Who invested in LenoMed Medical?
LenoMed Medical has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LenoMed Medical raised?
LenoMed Medical has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did LenoMed Medical last raise money?
LenoMed Medical's most recent round on record is a Series C, in Jun 2021.
What does LenoMed Medical do?
Based in Shanghai, China and established in 2014, LenoMed Medical is a medical technology that engages in the research and development and manufacturing of drug infusion devices.
Where is LenoMed Medical headquartered?
LenoMed Medical is headquartered in Shanghai, China.
Which VCs invest in companies like LenoMed Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at LenoMed Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like LenoMed Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.